Oncosoft CEO Kim Jin-sung takes acommemorative photo after winning the K-BioHealth Grand Prize in the categoryof 'AI Anti-cancer Treatment SW' for the second consecutive year at the '202410th Korea Industry Awards' hosted by MoneyToday.
Oncosoft is a developer of artificialintelligence (AI) software (SW) for radiation cancer therapy. It is the onlycompany in the industry that supports specialized solutions for high-technologyradiation therapy and has an AI automatic contouring product approved by theKorea Food and Drug Administration. The company recently established a localsubsidiary in the United States and is preparing to enter the global market.
